Guohua Jia Shuimei Zhou Tangpeng Xu Yabing Huang Xiangpan Li
10.3389/fonc.2022.954685
Front Oncol
2022 Sep 14;12:954685.
conversion therapy immunotherapy locally advanced squamous cell carcinoma unresectable lung cancer
CC BY
https://pubmed.ncbi.nlm.nih.gov/36185263/
PMC9515488
36185263
Conversion therapy from unresectable stage IIIC non-small-cell lung cancer to radical surgery via anti-PD-1 immunotherapy combined with chemotherapy and anti-angiogenesis: A case report and literature review
2022